Все публикации

0:22:34

ProImmune T cell Proliferation Assays

0:25:19

ProPresent Antigen Presentation Assay Webcast

0:23:03

Kevin Maringer: Role of mosquito NF-κB-mediated innate immunity in control of virus transmission

0:20:19

Sam Benton: Ankyrons™: Next-generation target-binding reagents beyond antibodies

0:16:26

Peter Eggenhuizen: Autoantigen-specific T regulatory cells halt the progression of lupus nephritis

0:20:49

Alexander Nicols: Understanding the Impact of Hybrid Immunity on SARS-CoV-2 T Cell Memory

0:19:16

Ashley Curran: Citrullination alters antigen processing and presentation by revealing epitopes in RA

0:18:31

Emilee Knowlton: MHC Class I Pentamers and MHC Class II Tetramers to track antigen-specific T cells

0:20:14

Genevieve Clutton: CD3 downregulation identifies high-avidity human CD8 T cells

0:21:53

Máté Manczinger: Neoantigen repertoire in the context of HLA class I shapes antitumor immunity

0:32:01

ProImmune Ankyron Webinar 29Jan2024

0:24:07

Koen Venken: Modulatory roles of Tregs in gut vs joint inflammation in TNF-driven spondyloarthritis

0:16:02

Mastering Immunity 2023: Experts Panel Discussion Session 2

0:27:04

Charlotte Thompson: Ankyrons: The future of target-binding reagents beyond antibodies

0:20:47

Noor Zayanah Hamis: Role of skin-based T cell immunity in acute dengue infection

0:20:11

Edmund Neo: Application of ProPresent® Antigen Presentation Assay to Assess Immunogenicity

0:19:46

Mastering Immunity 2023: Experts Panel Discussion Session 1

0:20:00

Georgia Stavrakis: Pre-conjugation of MHC Pentamers for simultaneous analysis of ag-specific T cells

0:25:42

Narasimha Rao: FDA recommendations on immunogenicity risk assessment for synthetic peptide drugs

0:20:33

Jennifer Malcolm: C-term citrullinated peptide alters APC-CD4 T cells leading to breach of tolerance

0:16:29

Peng Li: Immunogenicity Assessment during the development of antibody therapeutics

0:15:55

Yoonjoo Choi: Protein deimmunization by T cell epitope deletion

0:07:10

An Integrated Approach and Strategies to Mitigate Immunogenicity Risk

0:05:59

Evaluating immunogenicity risk of complex peptide products